Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04593758
Title To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613 (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Rafael Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of Kansas Medical Center Kansas City Kansas 66160 United States Details
University of Michigan Ann Arbor Michigan 48109 United States Details
Atrium Health Wake Forest Baptist Winston-Salem North Carolina 27109 United States Details
Clevland Clinic Ohio City Ohio 44195 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
Vanderbilt University Medical Centrer Nashville Tennessee 37232 United States Details
Seattle Children's Hospital Seattle Washington 98105 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field